The Power of Master Non-Disclosure Framework Agreements in Clinical Trials
Clinical trials in oncology are critical in advancing cancer research and developing innovative therapies that can improve patient outcomes. In…
A Stable Clinical Trial Study Team with Trial Legacy Capability Makes All the Difference
The smaller, niche CRO that is well managed, with stable clinical trial study teams that provide trial legacy capability, and…
25 Years of Unparalleled Canadian Oncology Clinical Research Experience
Scimega Research, Canada’s premier oncology contract research organization (CRO), was founded twenty-five years ago by two dynamic entrepreneurs, Denise Deakin…
eTMF Best Practice for a Lean Team
The TMF is the official record of the clinical study for Regulatory Authorities, be it the FDA, Health Canada, or…
Recovering a Derailed Clinical Trial – Best Practices
Partnerships sometimes do not work out as intended. For medium size and smaller biotech companies enlisting the services of a…
Doubly Nimble: why you should open global P1 clinical trials in Canada on Day 1
With agility increasingly becoming the most important global driver of success, it’s worth noting that Canadian oncology research center Phase…
Diversity in Clinical Trial Participants: Canada Holds Promise
Participant diversity in clinical trials can be quite challenging to achieve. With COVID the concern about appropriate demographic representation is…
Some Facts About Canada… Mitigate COVID-19 Impact on Your Clinical Trials
People often adhere to a myth and perpetuate it in answer to a difficult question, ending all further inquiry into…
Going Above-and-Beyond – What Can Your Specialized Oncology CRO Do for You?
Clinical research is a growing and fascinating field marked by increasing complexity and competitive surroundings. CROs can help their Sponsors…
Hassle-Free Site Selection and Study Start-up for Clinical Trials in Canada
It is no secret that Canada’s presence as a key player in the field of pharmaceutical drug development is rapidly…